Elena García-Villacieros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elena García-Villacieros has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ana López-Herranz
Laboratorio Central de Veterinaria, Ministry of Agriculture, Fisheries and Food, 28110 Algete, Spain
3 shared publications - Cristina Tena-Tomás
Tecnologías y Servicios Agrarios, S.A, (TRAGSATEC), 28006 Madrid, Spain
3 shared publications - Germán Cáceres-Garrido
Subdirección General de Sanidad e Higiene Animal y Trazabilidad, Ministry of Agriculture, Fisheries and Food (MAPA), 28014 Madrid, Spain
3 shared publications - Jorge Morales
Laboratorio Central de Veterinaria, Ministry of Agriculture, Fisheries and Food, 28110 Algete, Spain
3 shared publications - Marta Valero-Lorenzo
Laboratorio Central de Veterinaria, Ministry of Agriculture, Fisheries and Food, 28110 Algete, Spain
3 shared publications - María José Ruano
Laboratorio Central de Veterinaria (LCV), Ministry of Agriculture, Fisheries and Food, Ctra. M-106, pk 1,4, 28110 Algete, Spain
3 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 956
Exceptional Bluetongue Epidemic Caused by Co-Circulation of Several Serotypes in Spain in 2024
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral disease of ruminants, and has a severe impact on livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with a segmented genome (10 segments), belonging to the Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have mainly been controlled thanks to vaccination. In the case of Spain, from 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and, sporadically, BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact in sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, serotype 4 also circulated that year, especially in areas where the other serotypes were already circulating. Whole-genome sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTVs recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype-specific RT-PCRs, both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raise the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.
- 23 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 956
Open AccessExceptional Bluetongue Epidemic Caused by Co-Circulation of Several Serotypes in Spain in 2024
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral disease of ruminants, and has a severe impact on livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with a segmented genome (10 segments), belonging to the Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have mainly been controlled thanks to vaccination. In the case of Spain, from 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and, sporadically, BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact in sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, serotype 4 also circulated that year, especially in areas where the other serotypes were already circulating. Whole-genome sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTVs recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype-specific RT-PCRs, both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raise the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.
- Open Access
- 24 March 2026
- Published by MDPI AG in Preprints.org
Exceptional Bluetongue Epidemic Caused by Co-Circulation of Several Serotypes in Spain in 2024
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral diseases of ruminants, producing severe impacts in livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with segmented genome (10 segments), belonging to Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have been controlled mainly thanks to vaccination. In the case of Spain, since 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and sporadically BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact especially on sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, also circulated serotype 4 that year, especially in areas where the other serotypes were already circulating. Whole Genome Sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTV viruses recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype specific RT-PCRs both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raises the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.
- 24 March 2026
- Published by MDPI AG in Preprints.org
Open AccessExceptional Bluetongue Epidemic Caused by Co-Circulation of Several Serotypes in Spain in 2024
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral diseases of ruminants, producing severe impacts in livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with segmented genome (10 segments), belonging to Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have been controlled mainly thanks to vaccination. In the case of Spain, since 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and sporadically BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact especially on sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, also circulated serotype 4 that year, especially in areas where the other serotypes were already circulating. Whole Genome Sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTV viruses recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype specific RT-PCRs both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raises the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.
- Open Access
- 13 February 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (2) , 411
Emerging Bluetongue Virus Serotype 4 in the Balearic Islands, Spain (2021): Outbreak Investigations and Experimental Infection in Sheep
Bluetongue is an infectious, non-contagious, arthropod-borne viral disease of ruminants caused by bluetongue virus (BTV), producing severe impacts on livestock. Historically, Southern Europe has suffered multiple incursions of different BTV serotypes with serious consequences. In 2021, BTV re-emerged in the Balearic Islands (Spain) after 16 years free of the disease, causing a large outbreak that mainly affected sheep, as well as cattle and goats. A novel emerging strain of BTV serotype 4 (BTV-4) was identified via preliminary molecular characterization as the etiological culprit of the epizootic. This study delineates the outbreak in the Balearic Islands in 2021, encompassing field-based clinical observations and laboratory findings. Additionally, an experimental infection was conducted in sheep using the novel BTV-4 strain to assess its virulence, pathogenicity, and laboratory diagnostic characteristics. The in vivo characterization was conducted concurrently with the virulent and widely disseminated BTV-4 RNM 2020 strain that has precipitated significant outbreaks in the Mediterranean region in recent years. Both strains exhibited analogous pathogenic potential in sheep and yielded equivalent outcomes in diagnostic parameters. Furthermore, the impact of the novel BTV-4 strain is discussed.
- 13 February 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (2) , 411
Open AccessEmerging Bluetongue Virus Serotype 4 in the Balearic Islands, Spain (2021): Outbreak Investigations and Experimental Infection in Sheep
Bluetongue is an infectious, non-contagious, arthropod-borne viral disease of ruminants caused by bluetongue virus (BTV), producing severe impacts on livestock. Historically, Southern Europe has suffered multiple incursions of different BTV serotypes with serious consequences. In 2021, BTV re-emerged in the Balearic Islands (Spain) after 16 years free of the disease, causing a large outbreak that mainly affected sheep, as well as cattle and goats. A novel emerging strain of BTV serotype 4 (BTV-4) was identified via preliminary molecular characterization as the etiological culprit of the epizootic. This study delineates the outbreak in the Balearic Islands in 2021, encompassing field-based clinical observations and laboratory findings. Additionally, an experimental infection was conducted in sheep using the novel BTV-4 strain to assess its virulence, pathogenicity, and laboratory diagnostic characteristics. The in vivo characterization was conducted concurrently with the virulent and widely disseminated BTV-4 RNM 2020 strain that has precipitated significant outbreaks in the Mediterranean region in recent years. Both strains exhibited analogous pathogenic potential in sheep and yielded equivalent outcomes in diagnostic parameters. Furthermore, the impact of the novel BTV-4 strain is discussed.